3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Withdrawn
1
Terminated
1
Recruiting
1
Not yet recruiting
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
22
Nasopharyngeal Carcinoma
11
Squamous Cell Carcinoma of Head and Neck
9
Small Cell Lung Carcinoma
9
Uterine Cervical Neoplasms
7
Biliary Tract Neoplasms
6
Urinary Bladder Neoplasms
5
Esophageal Squamous Cell Carcinoma
5
Cholangiocarcinoma
5
Lung Neoplasms
4
Head and Neck Neoplasms
4
Stomach Neoplasms
3
Neoplasm Metastasis
3
Nasopharyngeal Neoplasms
3
Endometrial Neoplasms
3
Ovarian Neoplasms
2
Neoplasms
2
NSCLC
2
Esophageal Neoplasms
2
Breast Neoplasms
2
Unresectable Locally Advanced or Metastatic Solid Tumors
1
Triple Negative Breast Neoplasms
1
Tongue Squamous Cell Carcinoma
1
Thyroid Neoplasms
1
Thymoma
1
Thymic epithelial tumor
1
Solid Tumor Cancer
1
Recurrence
1
Rare Tumour
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Interventions
pembrolizumab
1
Gemcitabine
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Klatskin Tumor
×
Cisplatin
×
Clear all
NCT06923475
2025-04-11
NEODISCO
Amsterdam UMC, location VUmc
Phase 2/3
Not yet recruiting
150 enrolled